Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome

Journal of the American Osteopathic Association

Volumn 102, Issue 12, 2002, Pages 682-684

  Peterlin, B Lee ^a   Flood, William ^a   Kothari, Milind J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmune disorder; Case report; Intravenous immunoglobulin; Lambert Eaton myasthenic syndrome; Small cell lung cancer; Voltage gated calcium channels

Indexed keywords

IMMUNOGLOBULIN;

AGED; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG USE; EATON LAMBERT SYNDROME; FEMALE; HUMAN; LUNG SMALL CELL CANCER; ORTHOSTATIC HYPOTENSION; TREATMENT OUTCOME; VISUAL IMPAIRMENT; XEROSTOMIA;

ACTION POTENTIALS; AGED; CARCINOMA, SMALL CELL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LAMBERT-EATON MYASTHENIC SYNDROME; LUNG NEOPLASMS; MEDIAN NERVE;

EID: 0036912832     PISSN: 00986151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Newsom-Davis J. A treatment algorithm for Lambert-Eaton myasthenic syndrome. Ann NY Acad Sci. 1998;841:817-822.
2. Tim RW, Massey JM, Sanders DB. Lambert Eaton myasthenic syndrome (LEMS). Clinical and electrodiagnostic features and response to therapy in 59 patients. Ann NY Acad Sci. 1998;841:823-826.
3. Maddison P, Newsom-Davis J, Mills KR, Souhami RL. Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Lancet. 1999;353:117-118.
4. Seneviratne U, de Silva R. Lambert-Eaton myasthenic syndrome, Postgrad Med J. 1999;75:516-520.
5. Kim YI, Neher E. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependant calcium channels. Science. 1988;239:405-408.
6. O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain. 1988;111:577-596.
7. Eaton LM, Lambert EH, Electromyography and electrical stimulation of nerves in diseases of the motor unit: Observations on a myasthenic syndrome associated with malignant tumors. JAMA. 1957;163:1117-1124.
8. Bain PG, Motomura M, Newsom-Davis J, Misbah SA, Chapel HM, Lee ML, et al. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Neurology. 1996;47:678-683.
9. Rich MM, Teener JW, Bird SJ. Treatment of Lambert-Eaton myasthenic syndrome with intravenous immunoglobulin. Muscle Nerve. 1997;20:614-615.